-
Neil and Anna Rasmussen
Neil and Anna Rasmussen’s $250,000 gift supports the groundbreaking colorectal cancer research of Kimmie Ng, MD, MPH, at Dana-Farber. Their generous support over time has already exceeded $1 million. This most recent gift focuses on the microbiome’s role in the disease’s development and treatment in patients under 45, aiding personalized treatments and improved detection efforts.
-
Stanley and Carol Riemer
Carol and Stanley Riemer’s most recent commitment has established the Riemer Family Fund for Pancreatic Cancer Early Detection at Dana-Farber, in honor of late relatives who developed pancreatic cancer. Under the leadership of Matthew Yurgelun, MD, their support aims to develop groundbreaking early detection blood tests for high-risk patients.
-
Laurie H. Glimcher, MD, honored with endowed chair
A generous group of Trustees, colleagues, friends, and supporters contributed over $3 million to establish the chair and commemorate Glimcher’s legacy.
-
Estate gift accelerates cancer care and research for years to come
Out of gratitude for the excellent care received by his late wife, Gerry Martineau left a generous bequest to support research and patient care at Dana-Farber.
-
Sweet family endows first-ever fellowship in Lynch syndrome
With their gifts to Dana-Farber, David and JoEllen Sweet hope to alleviate the burden of Lynch syndrome for future generations.
-
Van Allen named to Chandra Nohria Family Chair for AI in Cancer Research
This endowed chair is the first in the field of artificial intelligence to be established at Dana-Farber Cancer Institute.
-
The Dana-Farber Campaign: Stopping cancer before it starts
The Dana-Farber Campaign dramatically advanced the prevention, early detection, and interception of cancers on a wide variety of fronts.
-
Arthur David Levin
With a gift of $100,000, Arthur David Levin established the Andrew John Torino Fund for Esophageal Cancer in honor of a dear friend’s husband, Andrew. This fund will advance the development of a new test to detect circulating tumor DNA (ctDNA) in the blood, with the goal of determining the risk of cancer recurrence in…
-
LUNGevity Foundation
With grants totaling $400,000 from LUNGevity Foundation, Jaclyn LoPiccolo, MD, PhD, is researching prediction of genetic lung cancer risk in people under 45 and how risk factors may guide screening and therapeutic approaches; and Elliot Brea, MD, PhD, is exploring how a modified CAR T-cell therapy may be effective in treating non-small cell lung cancer.
-
Pediatric Cancer Research Foundation
The Pediatric Cancer Research Foundation has awarded a $200,000 research grant to Brian Crompton, MD, for his work to test a prognostic liquid biopsy approach for pediatric Ewing sarcoma.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.